Granulocytic Sarcoma: A Rare Cause of Wrist Pain.

Annals of Plastic Surgery
Christine V SchaefferBrent R DeGeorge

Abstract

Septic, inflammatory, or crystal-induced arthritis are common etiologies of wrist pain without antecedent trauma associated with pain, loss of motion, swelling, redness, and warmth. In this report, we detail the case of granulocytic sarcoma of the wrist that presented as acute wrist pain, swelling, and limitation in motion. Granulocytic sarcoma is an exceedingly rare extramedullary tumor associated with acute myeloblastic leukemia. It may be found in any part of the body; however, upper extremity involvement is uncommon. To our knowledge, this is the first description of granulocytic sarcoma occurring in the wrist joint.

References

Feb 5, 1998·Lancet·D L Goldenberg
Dec 16, 2006·Leukemia & Lymphoma·Semra PaydasMelek Ergin
Nov 2, 2007·Diagnostic Pathology·Borislav A AlexievXianfeng F Zhao
Oct 17, 2008·Journal of Cancer Research and Therapeutics·Kunhi Parambath HareshGoura Kishor Rath
Jan 14, 2009·Neurology·Chafic KaramDaniel J MacGowan
Dec 28, 2010·The Journal of Hand Surgery·Kshamata SkeeteMarco Rizzo
Jul 29, 2011·Blood·Richard L BakstJoachim Yahalom
Aug 30, 2011·Hand Clinics·Douglas M Sammer, Alexander Y Shin
Dec 7, 2013·Infection·T J KowalskiJ D Gundrum
Apr 1, 2011·Practical Radiation Oncology·Brandon M BarneyPeter S Rose
Sep 22, 2015·Hand Surgery : an International Journal Devoted to Hand and Upper Limb Surgery and Related Research : Journal of the Asia-Pacific Federation of Societies for Surgery of the Hand·Robert Tze Jin Yap, Shian Chao Tay
Feb 12, 2017·Annals of Plastic Surgery·Jeffrey R ClaiborneAnthony J Defranzo
Mar 28, 2017·Clinical Lymphoma, Myeloma & Leukemia·L Max AlmondAnant Desai
Jan 13, 2018·The Journal of the American Academy of Orthopaedic Surgeons·John D Jennings, Asif M Ilyas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Revista chilena de pediatría
M T PobleteC Zapata
Medical and Pediatric Oncology
D K ShahC A Felix
Medical and Pediatric Oncology
A TorneselloR Mastrangelo
Indian Journal of Pathology & Microbiology
S NarayanA Bais
AJNR. American Journal of Neuroradiology
F A Jakobiec
© 2021 Meta ULC. All rights reserved